• Jefe de OMS Cumbre China 2021-09-22
  • Funcionários do governo e especialistas pedem maior cooperao para reviver turismo global 2021-09-22
  • Funcionario del PRD panameo destaca rol del PCCh Spanish.xinhuanet.com 2021-09-22
  • CBA股东大会 提交两套方案 2021-09-21
  • Ampliao Xi visita Nyingchi no Tibet 2021-09-21
  • 7月起海南离岛旅客每年每人免税购物额度提至10万元 2021-09-20
  • 6月19日广东无新增本土确诊病例 2021-09-20
  • 6月18日译名发布:Kenneth Kaunda 2021-09-20
  • 3岁女童不慎落入水塘 重病大叔毫不犹豫出手相救 2021-09-19
  • 2米高“巨型稻”在重庆大足试种成功 2021-09-19
  • 2021湖南高考开考 57万余考生奔赴“新高考” 2021-09-18
  • 2021湖南车展4月30日至5月5日举行 2021-09-18
  • 2021年福州国际友城文化节开幕 2021-09-18
  • 2021年神农架自驾文化旅游节论坛在大九湖举行 2021-09-18
  • 2021年全国科普日山东省主场活动启动 2021-09-17
  • Global EditionASIA 中文双语Fran?ais
    Home / Regional / Regions

    Pfizer attends 21st CIFIT in Xiamen

    www.gospeljazzbyhlsteins.com | Updated: 2021-09-10 15:44
    Share - WeChat

    大发快3-首页 www.gospeljazzbyhlsteins.com "This is the first time that Pfizer has attended the high-level fair. I'm very impressed with the scale, quality, and results of the fair," said Yang Ying, Pfizer Vice-President, Worldwide Business Development Asia Lead, during an interview at the 21st China International Fair for Investment and Trade (CIFIT) in Xiamen, Fujian province.

    Yang Ying, Pfizer Vice-President, Worldwide Business Development Asia Lead. [Photo/www.gospeljazzbyhlsteins.com]

    "The 21st CIFIT offers a platform for us to display Pfizer's innovation achievements, as well as a platform to communicate with governments and industry peers," said Yang.

    Yang also shared her insights on China's new drug research and development.

    "China's innovation medicine ecosystem has improved. I think within five years, China will become the second largest R&D base for innovative drugs in the world, surpassing Europe," said Yang.

    Yang said that China's policy reforms in recent years have created huge development opportunities for foreign pharmaceutical companies and enabled foreign pharmaceutical companies to bring international innovative drugs into China faster, benefiting millions of Chinese patients.

    At the same time, Pfizer can bring innovative drugs from China to the world and benefit patients all over the world, said Yang.

    Founded in 1849 and headquartered in New York, Pfizer is a science-based, innovative, and patient-focused bio-pharmaceutical company.

    In 2020, Pfizer had a revenue of $41.9 billion. It also ranked 215th in the Fortune Global 500 that year.

    Since entering the Chinese market in 1989, Pfizer has become one of the leading foreign pharmaceutical companies in the country. So far, Pfizer has invested over $1.5 billion in China, with a presence in over 300 cities nationwide and a total staff of almost 7,000, covering business, R&D, and manufacturing in China.

    Copyright 1995 - . All rights reserved. The content (including but not limited to text, photo, multimedia information, etc) published in this site belongs to China Daily Information Co (CDIC). Without written authorization from CDIC, such content shall not be republished or used in any form. Note: Browsers with 1024*768 or higher resolution are suggested for this site.
    License for publishing multimedia online 0108263

    Registration Number: 130349